As the Otsuka VP of applied innovation and process improvement, Debbie Profit spends a lot of her time thinking about the future of clinical trials. “There are changes occurring in the industry that will force clinical development executives to shift their mindset,” says Profit. “I am trying to understand what clinical trial sites will look like going forward.”
Every day, the eSource revolution is reducing organizations’ reliance on monitoring visits and source data verification — and thus serving as a crucial safety net in the event of unforeseen changes to monitoring staff, particularly the ability to minimize the disruption caused when a CRA leaves an organization mid-study.
By Kevin Olson, Industry Standard Research
Service marketers are often evaluated on results outside of their control and on nonstrategic measures. However, service marketers can take control of their marketing performance by implementing credible marketing effectiveness measures and creating their own narrative.
Given the rapidly changing landscape of today's trials, if sponsors wish to succeed, they must remain vigilant — attending to every detail of the process. Learn more about how several sponsors achieved success through these case study examples.
In this webinar, Dr. Frank Smith explores advances in precision medicine and how it is affecting clinical research. As a pediatric hematologist/oncologist, he will use his extensive clinical and research background as a backdrop for the discussion.